info@revela.bio
1 Broadway Suite 14, Cambridge MA 0214
Revela leverages our deep experience in developing single-domain antibody fragments, VHHs, that have faster clearance, improved tissue penetration and cost-efficient manufacturing. With our novel tools and techniques, we are able to offer ImunnoPET imaging solutions for improved patient outcomes.